Routinely collected data and comparative effectiveness evidence: promises and limitations

Affiliations

¹ Stanford Prevention Research Center (Hemkens, Ioannidis), Department of Medicine, Stanford University School of Medicine, Stanford, Calif.; Basel Institute for Clinical Epidemiology and Biostatistics (Hemkens), University Hospital Basel, Basel, Switzerland; Division of Infectious Diseases, Department of Pediatrics (Contopoulos-Ioannidis), Stanford University School of Medicine; Meta-Research Innovation Center at Stanford (METRICS) (Contopoulos-Ioannidis, Ioannidis); Department of Health Research and Policy (Ioannidis), Stanford University School of Medicine; Department of Statistics (Ioannidis), Stanford University School of Humanities and Sciences, Stanford, Calif.
² Stanford Prevention Research Center (Hemkens, Ioannidis), Department of Medicine, Stanford University School of Medicine, Stanford, Calif.; Basel Institute for Clinical Epidemiology and Biostatistics (Hemkens), University Hospital Basel, Basel, Switzerland; Division of Infectious Diseases, Department of Pediatrics (Contopoulos-Ioannidis), Stanford University School of Medicine; Meta-Research Innovation Center at Stanford (METRICS) (Contopoulos-Ioannidis, Ioannidis); Department of Health Research and Policy (Ioannidis), Stanford University School of Medicine; Department of Statistics (Ioannidis), Stanford University School of Humanities and Sciences, Stanford, Calif. jioannid@stanford.edu.

Lars G Hemkens et al. CMAJ. 2016.

. 2016 May 17;188(8):E158-E164.

doi: 10.1503/cmaj.150653. Epub 2016 Feb 16.

¹ Stanford Prevention Research Center (Hemkens, Ioannidis), Department of Medicine, Stanford University School of Medicine, Stanford, Calif.; Basel Institute for Clinical Epidemiology and Biostatistics (Hemkens), University Hospital Basel, Basel, Switzerland; Division of Infectious Diseases, Department of Pediatrics (Contopoulos-Ioannidis), Stanford University School of Medicine; Meta-Research Innovation Center at Stanford (METRICS) (Contopoulos-Ioannidis, Ioannidis); Department of Health Research and Policy (Ioannidis), Stanford University School of Medicine; Department of Statistics (Ioannidis), Stanford University School of Humanities and Sciences, Stanford, Calif.
² Stanford Prevention Research Center (Hemkens, Ioannidis), Department of Medicine, Stanford University School of Medicine, Stanford, Calif.; Basel Institute for Clinical Epidemiology and Biostatistics (Hemkens), University Hospital Basel, Basel, Switzerland; Division of Infectious Diseases, Department of Pediatrics (Contopoulos-Ioannidis), Stanford University School of Medicine; Meta-Research Innovation Center at Stanford (METRICS) (Contopoulos-Ioannidis, Ioannidis); Department of Health Research and Policy (Ioannidis), Stanford University School of Medicine; Department of Statistics (Ioannidis), Stanford University School of Humanities and Sciences, Stanford, Calif. jioannid@stanford.edu.

No abstract available

References

1. Hsing AW, Ioannidis JP. Nationwide population science: lessons from the Taiwan National Health Insurance Research Database. JAMA Intern Med. 2015;175:1527–9. - PubMed
1. Hernán MA, Robins JM. Instruments for causal inference: An epidemiologist’s dream? Epidemiology 2006;17:360–72. - PubMed
1. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 2005;58:323–37. - PubMed
1. Bohensky MA, Jolley D, Sundararajan V, et al. Data linkage: a powerful research tool with potential problems. BMC Health Serv Res 2010;10:346. - PMC - PubMed
1. Naci H, Ioannidis JP. Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study. BMJ 2013;347:f5577. - PMC - PubMed